Biodegradable Materials for Drug Delivery

A special issue of Journal of Functional Biomaterials (ISSN 2079-4983).

Deadline for manuscript submissions: closed (31 March 2018) | Viewed by 8723

Special Issue Editor


E-Mail Website
Guest Editor
Institute of Polymer Chemistry (ICP), Johannes Kepler University Linz, Altenberger Str. 69, 4040 Linz, Austria
Interests: functional polymers; polymer degradation; biomedical polymers; biomimetic polymers; molecularly imprinted polymers; bionics; high performance polymers; industrial aspects of polymers
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Treatment of patients very often requires the use of pharmaceutically-active substances, to be administered in a controlled way. The chosen drugs are usually linked with, or imbedded in, a matrix, allowing, in many cases, not only the control of the delivery of a drug carrier system to a specific target site, but also of the following release of the active agent at that location. The subsequent and often-unsolved challenge, however, is the fate of the carrier matrices. Various carriers, with a number of them being biodegradable, have been developed over the years. Nevertheless, some tend to accumulate in a patient’s body, showing no or only retarded degradation effects; some are degraded into harmful, or at least tissue irritating, fragments. Hence, current research efforts are directed to enhance the biodegradability of such matrices or to develop novel carrier systems without the named drawbacks. Optimal future carrier materials should, not only be equipped with the ability to deliver and release the drugs solely where and when being needed, but should also be provided with degradation timers, based on their molecular designs, leading to harmless fragmentation products.

This Special Issue, “Biodegradable Materials for Drug Delivery”, covers the different classes of biodegradable materials used for drug delivery approaches, such as natural and synthetic polymers, or inorganic materials, such as ceramics and metals. It highlights established delivery systems like hydrogels, supramolecular structures, nanoparticles or lipid-based carriers, describes the variety of applied dosage forms in this context like capsules, patches, or solutions, and addresses the aspect of biocompatibility of these materials, i.e., their impact on livings cells and tissues. Furthermore, the drug release from these materials, triggered by different stimuli, as well as promising smart delivery concepts are explained. Finally, the actual degradation process caused by stimuli like pH-shift, enzymes, temperature, or combinations thereof will be discussed.

Prof. Dr. Oliver Brüggemann
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Natural polymers
  • Synthetic polymers
  • Biodegradable inorganic materials
  • Composite and hybrid materials
  • Hydrogels
  • Supramolecular structures and nanoparticles
  • Lipids
  • Dosage forms of biodegradable drug delivery systems
  • Biocompatibility - interaction with cells and tissues
  • Stimuli responsive drug release
  • Smart drug delivery
  • Stimuli responsive degradation

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

9 pages, 2075 KiB  
Article
Encapsulation and Characterization of Gentamicin Sulfate in the Collagen Added Electrospun Nanofibers for Skin Regeneration
by Wan Khartini Wan Abdul Khodir, Abdul Hakim Abdul Razak, Min Hwei Ng, Vincenzo Guarino and Deny Susanti
J. Funct. Biomater. 2018, 9(2), 36; https://doi.org/10.3390/jfb9020036 - 18 May 2018
Cited by 48 | Viewed by 8218
Abstract
In the current practice, the clinical use of conventional skin substitutes such as autogenous skin grafts have shown several problems, mainly with respect to limited sources and donor site morbidity. In order to overcome these limitations, the use of smart synthetic biomaterials is [...] Read more.
In the current practice, the clinical use of conventional skin substitutes such as autogenous skin grafts have shown several problems, mainly with respect to limited sources and donor site morbidity. In order to overcome these limitations, the use of smart synthetic biomaterials is tremendously diffusing as skin substitutes. Indeed, engineered skin grafts or analogues frequently play an important role in the treatment of chronic skin wounds, by supporting the regeneration of newly formed tissue, and at the same time preventing infections during the long-term treatment. In this context, natural proteins such as collagen—natively present in the skin tissue—embedded in synthetic polymers (i.e., PCL) allow the development of micro-structured matrices able to mimic the functions and to structure of the surrounding extracellular matrix. Moreover, the encapsulation of drugs, such as gentamicin sulfate, also improves the bioactivity of nanofibers, due to the efficient loading and a controlled drug release towards the site of interest. Herein, we have done a preliminary investigation on the capability of gentamicin sulfate, loaded into collagen-added nanofibers, for the controlled release in local infection treatments. Experimental studies have demonstrated that collagen added fibers can be efficaciously used to administrate gentamicin for 72 h without any toxic in vitro response, thus emerging as a valid candidate for the therapeutic treatment of infected wounds. Full article
(This article belongs to the Special Issue Biodegradable Materials for Drug Delivery)
Show Figures

Graphical abstract

Back to TopTop